Skip to main content
Medical Data Vision Co.,Ltd. logo

Medical Data Vision Co.,Ltd. — Investor Relations & Filings

Ticker · 3902 ISIN · JP3921250001 T Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 73 across all filing types
Latest filing 2026-05-13 Transaction in Own Shar…
Country JP Japan
Listing T 3902

About Medical Data Vision Co.,Ltd.

https://en.mdv.co.jp/

Medical Data Vision Co., Ltd. (MDV) is a healthcare data provider that operates one of the largest medical databases in its market. The company aggregates and processes real-world administrative data from hundreds of hospitals, encompassing records for over 50 million patients. This database provides detailed insights into treatment patterns, patient conditions, and medication decision-making. MDV offers data and analytical services primarily to pharmaceutical companies, medical device manufacturers, and research institutions for use in research, development, and market analysis. Additionally, the company provides information and communication technology (ICT) solutions and management support systems for medical institutions.

Recent filings

Filing Released Lang Actions
臨時報告書
Transaction in Own Shares Classification · 93% confidence The document is a Japanese “臨時報告書” (Timely Report) filed under the Financial Instruments and Exchange Act, disclosing the company’s acquisition of its own shares (“自己株式の取得”) which leads to a change in a major shareholder’s voting rights. This is a direct report of a share repurchase by the issuer. Under our taxonomy, such reports fall under Transaction in Own Shares (Code: POS).
2026-05-13 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の４の２第１項' (Article 24-4-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification confirming the accuracy of the company's Annual Securities Report (有価証券報告書). Per the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. FY 2025
2026-03-24 Japanese
有価証券報告書－第23期(2025/01/01－2025/12/31)
Annual Report Classification · 100% confidence The document is a '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese Annual Securities Report required under the Financial Instruments and Exchange Act. It contains comprehensive financial data, including consolidated and non-consolidated financial indicators, for the fiscal year ending December 31, 2025. This document serves as the official annual report for the company. FY 2025
2026-03-24 Japanese
意見表明報告書
Regulatory Filings Classification · 97% confidence The document is an 'Opinion Statement Report' (意見表明報告書) filed by Medical Data Vision Co., Ltd. in response to a tender offer (公開買付け) initiated by Nippon Life Insurance Company. This document is a formal regulatory filing required under the Financial Instruments and Exchange Act of Japan, where the target company's board expresses its opinion (support/recommendation) regarding the takeover bid. This fits the definition of a regulatory filing related to M&A activity and board governance, but specifically falls under the 'Regulatory Filings' (RNS) category as it is a formal statutory disclosure document regarding a tender offer response.
2025-12-16 Japanese
半期報告書－第23期(2025/01/01－2025/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) for Medical Data Vision Co., Ltd., covering the period from January 1, 2025, to June 30, 2025. It contains detailed financial statements, including the balance sheet, income statement, and cash flow statement, as well as management analysis. This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data for a period shorter than a full fiscal year. H1 2025
2025-08-13 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under Article 24-5-2 of the Financial Instruments and Exchange Act of Japan. This is a mandatory regulatory filing that accompanies the submission of a semi-annual or quarterly report to the Kanto Local Finance Bureau, confirming the accuracy of the report's contents. Since it is a specific regulatory filing required by law and does not fit into the other categories like 'Interim Report' (which would be the report itself) or 'Earnings Release', it is best classified as a Regulatory Filing (RNS).
2025-08-13 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.